{"Symbol": "AMIX", "AssetType": "Common Stock", "Name": "Autonomix Medical, Inc. Common Stock", "Description": "Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company is headquartered in The Woodlands, Texas.", "CIK": "1617867", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "MEDICAL DEVICES", "Address": "21 WATERWAY AVENUE, THE WOODLANDS, TX, UNITED STATES, 77380", "OfficialSite": "https://autonomix.com", "FiscalYearEnd": "March", "LatestQuarter": "2025-12-31", "MarketCapitalization": "2647700", "EBITDA": "-16854000", "PERatio": "None", "PEGRatio": "None", "BookValue": "3.243", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-4.51", "RevenuePerShareTTM": "0", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-1.593", "ReturnOnEquityTTM": "-3.524", "RevenueTTM": "0", "GrossProfitTTM": "0", "DilutedEPSTTM": "-4.51", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0", "AnalystTargetPrice": "2", "AnalystRatingStrongBuy": "1", "AnalystRatingBuy": "1", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "-", "PriceToSalesRatioTTM": "-", "PriceToBookRatio": "0.411", "EVToRevenue": "-", "EVToEBITDA": "-", "Beta": "-2.561", "52WeekHigh": "3.09", "52WeekLow": "0.342", "50DayMovingAverage": "0.544", "200DayMovingAverage": "1.107", "SharesOutstanding": "6907700", "SharesFloat": "6533600", "PercentInsiders": "6.713", "PercentInstitutions": "5.422", "DividendDate": "None", "ExDividendDate": "None"}